<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">role-of-adhesion-receptors-in-mast-cell-disease-ev</item><item key="factor_count">1</item><item key="sample_count">2</item><item key="tags"><item>cell</item><item>leukemia</item><item>line</item><item>mastocytosis</item><item>organ</item><item>peritoneum</item><item>p-selectin</item><item>scid</item><item>selectin</item><item>solid</item><item>surface</item><item>systemic mastocytosis</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33504</item><item key="id">2614</item><item key="name">Role of adhesion receptors in mast cell disease-evolution</item></item><item><item key="slug">role-of-mir-146a-on-jurkat-t-cells</item><item key="factor_count">1</item><item key="sample_count">3</item><item key="tags"><item>cell</item><item>line</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-21132</item><item key="id">3622</item><item key="name">role of miR-146a on Jurkat T cells</item></item><item><item key="slug">s100p-is-a-metastasis-associated-gene-that-facil-3</item><item key="factor_count">1</item><item key="sample_count">7</item><item key="tags"><item>cancer</item><item>cell</item><item>line</item><item>pancreatic cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19278</item><item key="id">2322</item><item key="name">S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells [HG-U133_Plus_2]</item></item><item><item key="slug">sbv-gene-expression-profiles-of-lung-cancer-tumors</item><item key="factor_count">20</item><item key="sample_count">150</item><item key="tags"><item>adenocarcinoma</item><item>cancer</item><item>carcinoma</item><item>cell</item><item>lung</item><item>lung cancer</item><item>lymph</item><item>lymph node</item><item>squamous</item><item>squamous cell</item><item>squamous cell carcinoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-43580</item><item key="id">2252</item><item key="name">SBV - Gene Expression Profiles of Lung Cancer Tumors - Adenocarcinomas and Squamous Cell Carcinomas</item></item><item><item key="slug">sdf-1-induced-transcriptional-changes-in-human-cor</item><item key="factor_count">1</item><item key="sample_count">8</item><item key="tags"><item>cell</item><item>chemokine</item><item>genome</item><item>stromal cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-20891</item><item key="id">3610</item><item key="name">SDF-1 induced transcriptional changes in human cord blood CD34+ cells</item></item><item><item key="slug">selective-requirement-for-mediator-med23-in-ras-ac</item><item key="factor_count">0</item><item key="sample_count">9</item><item key="tags"><item>cancer</item><item>cell</item><item>genome</item><item>lung</item><item>lung cancer</item><item>nsclc</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-40517</item><item key="id">2303</item><item key="name">Selective Requirement for Mediator MED23 in Ras-active Lung Cancer</item></item><item><item key="slug">sema4a-a-novel-serum-marker-of-multiple-sclerosis</item><item key="factor_count">2</item><item key="sample_count">10</item><item key="tags"><item>autoimmune disease</item><item>cell</item><item>central</item><item>disease</item><item>encephalomyelitis</item><item>hand</item><item>multiple sclerosis</item><item>nervous system</item><item>peripheral</item><item>relapsing-remitting ms</item><item>serum</item><item>surface</item><item>syndrome</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26484</item><item key="id">3912</item><item key="name">Sema4A, a novel serum marker of multiple sclerosis, implicates Th17 pathology and efficacy of interferon-&#946;.</item></item><item><item key="slug">sequential-gene-expression-profiling-in-cll-during</item><item key="factor_count">1</item><item key="sample_count">50</item><item key="tags"><item>cell</item><item>chronic lymphocytic leukemia</item><item>leukemia</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-15490</item><item key="id">3236</item><item key="name">Sequential gene expression profiling in CLL during treatment</item></item><item><item key="slug">serum-follistatin-like-protein-1-is-a-biomarker-fo</item><item key="factor_count">5</item><item key="sample_count">11</item><item key="tags"><item>arthritis</item><item>cell</item><item>disease</item><item>erythrocyte</item><item>glycoprotein</item><item>juvenile idiopathic arthritis</item><item>macrophage</item><item>peripheral</item><item>protein</item><item>serum</item><item>syndrome</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-38849</item><item key="id">2161</item><item key="name">Serum Follistatin-Like Protein 1 Is a Biomarker for Macrophage Activation Syndrome and May Predict Disease Course in Systemic Juvenile Idiopathic Arthritis</item></item><item><item key="slug">sharp1-suppresses-breast-cancer-metastasis-by-prom</item><item key="factor_count">1</item><item key="sample_count">12</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>cell phenotype</item><item>left</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33950</item><item key="id">4320</item><item key="name">SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors</item></item></data></biogps>
